CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Yopp, Adam C ^a   Shia, Jinru ^b   Butte, Jean M ^b   Allen, Peter J ^b   Fong, Yuman ^b   Jarnagin, William R ^b   Dematteo, Ronald P ^b   D'Angelica, Michael I ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; COLORECTAL CANCER; COLORECTAL CANCER HEPATIC METASTASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PARTIAL HEPATECTOMY; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; RISK FACTOR; SALVAGE THERAPY; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOKINE CXCL12; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR7; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES;

EID: 84865020846     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1774-4     Document Type: Article

References (43)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin. 58 71 96 18287387 10.3322/CA.2007.0010
2. L Vigano A Ferrero R Lo Tesoriere L Capussotti 2008 Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity Ann Surg Oncol. 15 2458 2464 18463927 10.1245/s10434-008-9935-9
3. RC Newland OF Dent PH Chapuis EL Bokey 1993 Clinicopathologically diagnosed residual tumor after resection for colorectal cancer. A 20-year prospective study Cancer 72 1536 1542 8348488 10.1002/1097-0142(19930901)72: 5<1536::AID-CNCR2820720508>3.0.CO;2-U 1:STN:280:DyaK3szltFSlsw%3D%3D
4. JS Tomlinson WR Jarnagin RP DeMatteo, et al. 2007 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol. 25 4575 4580 17925551 10.1200/JCO.2007.11.0833
5. MC de Jong C Pulitano D Ribero, et al. 2009 Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients Ann Surg. 250 440 448 19730175
6. TA Aloia R Adam D Azoulay H Bismuth D Castaing 2006 Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience HPB (Oxford) 8 100 105 10.1080/13651820500496266
7. JS Wagner MA Adson JA Van Heerden MH Adson DM Ilstrup 1984 The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment Ann Surg. 199 502 508 6721600 10.1097/00000658-198405000- 00002 1:STN:280:DyaL2c3gt1Sjuw%3D%3D
8. CB Wood CR Gillis LH Blumgart 1976 A retrospective study of the natural history of patients with liver metastases from colorectal cancer Clin Oncol. 2 285 288 1009711 1:STN:280:DyaE2s%2FptVSnuw%3D%3D
9. J Scheele R Stangl A Altendorf-Hofmann 1990 Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history Br J Surg. 77 1241 1246 2253003 10.1002/bjs.1800771115 1:STN:280: DyaK3M%2FntVajsw%3D%3D
10. Y Fong J Fortner RL Sun MF Brennan LH Blumgart 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg. 230 309 318 10493478 10.1097/00000658-199909000-00004 1:STN:280:DyaK1MvitFahsw%3D%3D
11. TJ Gayowski S Iwatsuki JR Madariaga, et al. 1994 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors Surgery. 116 703 710 7940169 1:STN:280:DyaK2M%2Fis1Cmtg%3D%3D
12. B Nordlinger M Guiguet JC Vaillant, et al. 1996 Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77 1254 1262 8608500 10.1002/(SICI)1097-0142(19960401)77: 7<1254::AID-CNCR5>3.0.CO;2-I 1:STN:280:DyaK287pslCiuw%3D%3D
13. SC Katz V Pillarisetty ZM Bamboat, et al. 2009 T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases Ann Surg Oncol. 16 2524 2530 19568816 10.1245/s10434-009-0585-3
14. M Gonen A Hummer A Zervoudakis, et al. 2003 Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer J Clin Oncol. 21 406 412 12560427 10.1200/JCO.2003.06.060 1:CAS:528:DC%2BD2cXpsVGrt7o%3D
15. A Zlotnik O Yoshie 2000 Chemokines: a new classification system and their role in immunity Immunity. 12 121 127 10714678 10.1016/S1074-7613(00)80165-X 1:CAS:528:DC%2BD3cXhslKqsL8%3D
16. A Muller B Homey H Soto, et al. 2001 Involvement of chemokine receptors in breast cancer metastasis Nature. 410 50 56 11242036 10.1038/35065016 1:CAS:528:DC%2BD3MXhvVSgu74%3D
17. Y Zhou PH Larsen C Hao VW Yong 2002 CXCR4 is a major chemokine receptor on glioma cells and mediates their survival J Biol Chem. 277 49481 49487 12388552 10.1074/jbc.M206222200 1:CAS:528:DC%2BD38XpsFaks7c%3D
18. AJ Minn GP Gupta PM Siegel, et al. 2005 Genes that mediate breast cancer metastasis to lung Nature. 436 518 524 16049480 10.1038/nature03799 1:CAS:528:DC%2BD2MXmsFCgs7o%3D
19. S Scala A Ottaiano PA Ascierto, et al. 2005 Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma Clin Cancer Res. 11 1835 1841 15756007 10.1158/1078-0432.CCR-04-1887 1:CAS:528:DC%2BD2MXitVKrs7k%3D
20. A Orimo PB Gupta DC Sgroi, et al. 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell. 121 335 348 15882617 10.1016/j.cell.2005. 02.034 1:CAS:528:DC%2BD2MXktlSiu7w%3D
21. O Kollmar K Rupertus C Scheuer, et al. 2010 CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1 Int J Cancer. 126 1302 1315 19821487 1:CAS:528:DC%2BC3cXps1alsQ%3D%3D
22. R Matsusue H Kubo S Hisamori, et al. 2009 Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis Ann Surg Oncol. 16 2645 2653 19588204 10.1245/s10434-009-0599-x
23. P Gassmann J Haier K Schluter, et al. 2009 CXCR4 regulates the early extravasation of metastatic tumor cells in vivo Neoplasia. 11 651 661 19568410 1:CAS:528:DC%2BD1MXnsFSrtbo%3D
24. J Kim H Takeuchi ST Lam, et al. 2005 Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival J Clin Oncol. 23 2744 2753 15837989 10.1200/JCO.2005.07.078 1:CAS:528:DC%2BD2MXktleqtrg%3D
25. J Kim T Mori SL Chen, et al. 2006 Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome Ann Surg. 244 113 120 16794396 10.1097/01.sla.0000217690.65909.9c
26. N Cabioglu A Sahin M Doucet, et al. 2005 Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow Clin Exp Metastasis. 22 39 46 16132577 10.1007/s10585-005- 3222-y 1:CAS:528:DC%2BD2MXhtFegtrfE
27. J Mizell M Smith BD Li F Ampil QD Chu 2009 Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study Ann Surg Oncol. 16 2711 2716 19593633 10.1245/s10434-009-0551-0
28. S Iwasa T Yanagawa J Fan R Katoh 2009 Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis Anticancer Res. 29 4751 4758 20032431
29. L Wang B Yang Q Yang S Qiao Y Wang Y Sun 2009 Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis Clin Exp Metastasis. 26 1049 1054 19859817 10.1007/s10585-009-9294-3 1:CAS:528:DC%2BD1MXhsVWlsrfM
30. IS Zeelenberg L Ruuls-Van Stalle E Roos 2003 The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases Cancer Res. 63 3833 3839 12839981 1:CAS:528:DC%2BD3sXltVGqs7k%3D
31. S Shimizu N Yamada T Sawada, et al. 2000 In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells Jpn J Cancer Res. 91 1285 1295 11123428 10.1111/j.1349-7006.2000.tb00916.x 1:CAS:528:DC%2BD3MXosFai
32. T Schioppa B Uranchimeg A Saccani, et al. 2003 Regulation of the chemokine receptor CXCR4 by hypoxia J Exp Med. 198 1391 1402 14597738 10.1084/jem.20030267 1:CAS:528:DC%2BD3sXovVKiurY%3D
33. JA Burger TJ Kipps 2006 CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment Blood. 107 1761 1767 16269611 10.1182/blood-2005-08-3182 1:CAS:528:DC%2BD28XitFChsLo%3D
34. F Hong A Tuyama TF Lee, et al. 2009 Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation Hepatology. 49 2055 2067 19434726 10.1002/hep.22890 1:CAS:528:DC%2BD1MXotVCmuro%3D
35. RJ Phillips M Lutz B Premack 2005 Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation J Inflamm (Lond). 2 14 10.1186/1476-9255-2-14
36. X Shen A Artinyan D Jackson RM Thomas AM Lowy J Kim 2010 Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways Pancreas. 39 81 87 19820417 10.1097/MPA.0b013e3181bb2ab7 1:CAS:528:DC%2BD1MXhsFyhs7fJ
37. M Monterrubio M Mellado AC Carrera JM Rodriguez-Frade 2009 PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion Biochem Biophys Res Commun. 388 199 204 19660434 10.1016/j.bbrc.2009.07.153 1:CAS:528: DC%2BD1MXhtVOisr3L
38. JB Rubin AL Kung RS Klein, et al. 2003 A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci USA. 100 13513 13518 14595012 10.1073/pnas.2235846100 1:CAS:528: DC%2BD3sXptFOit78%3D
39. F Marchesi P Monti BE Leone, et al. 2004 Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4 Cancer Res. 64 8420 8427 15548713 10.1158/0008-5472.CAN-04-1343 1:CAS:528:DC%2BD2cXpvVGks74%3D
40. Z Liang T Wu H Lou, et al. 2004 Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4 Cancer Res. 64 4302 4308 15205345 10.1158/0008-5472.CAN-03-3958 1:CAS:528:DC%2BD2cXkvFWlsbs%3D
41. SY Kim CH Lee BV Midura, et al. 2008 Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases Clin Exp Metastasis. 25 201 211 18071913 10.1007/s10585-007-9133-3 1:CAS:528:DC%2BD1cXnt1ensL0%3D
42. CY Huang CY Lee MY Chen, et al. 2009 Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways J Cell Physiol. 221 204 212 19496172 10.1002/jcp.21846 1:CAS:528:DC%2BD1MXptlOnt78%3D
43. V De Falco V Guarino E Avilla, et al. 2007 Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer Cancer Res. 67 11821 11829 18089812 10.1158/0008-5472.CAN-07-0899